Applied Therapeutics Provides Regulatory Update on Galactose

Pre-NDA Meeting to be held with FDA this summer to discuss potential NDA submission for govorestat for treatment of Classic Galactosemia EMA Marketing Authorization Application for govorestat for...

Related Keywords

United States , Maeve Conneighton , Advanz Pharma , Shoshana Shendelman , Nasdaq , European Medicines Agency , Drug Administration , Therapeutics Inc , Twitter , Exchange Commission , Authorization Application , Classic Galactosemia , United States Food , Pre New Drug Application , Applied Therapeutics , Pediatric Investigational Plan , Aldose Reductase , About Applied , Aldose Reductase Inhibitor , Diabetic Cardiomyopathy , Private Securities Litigation Reform Act ,